Home / World / Archive by category Survey and Research

Archive by category Survey and Research

Junshi Biosciences Announces Positive Opinion from the European Medicines Agency’s CHMP For Toripalimab

SHANGHAI, July 26, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary TopAlliance Biosciences Inc. (TopAlliance Biosciences), announce that the Committee for Medicinal Products for Human Use (CHMP) of the [...]

Sandoz Launches Biosimilar Pyzchiva® (ustekinumab) across Europe, to Treat Chronic Inflammatory Diseases

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases Launch across Europe, starting today, strengthens well-established Sandoz immunology portfolio in Europe, leveraging existing footprint Pyzchiva® first ustekinumab biosimilar to launch in Europe with all reference medicine strengths, including 130mg vial initiation [...]

Bedford Metals Announces Phase 1 of Exploration Program for Close Lake Uranium Project

VANCOUVER, British Columbia, July 23, 2024 (Korea Bizwire) – Bedford Metals Corp. (TSX-V: BFM, FWB: O8D, ISIN: CA0762301012) (the “Company” or “Bedford”) is pleased to announce its 2024 Phase I field program for the Close Lake Uranium Project, located on the west side of the Athabasca Basin. Results from this program will be integrated with historical datasets [...]

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate

VANCOUVER, British Columbia, July 22, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for ZW191, [...]

Verisk Estimates Industry Insured Losses in U.S. for Hurricane Beryl Will Range Between USD 2 Billion to USD 3 Billion

BOSTON , July 19, 2024 (Korea Bizwire) – The Extreme Event Solutions group at Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, estimates industry insured losses to onshore property from wind in the U.S. for Hurricane Beryl will range between USD 2 billion to USD 3 billion. Meteorological History of Beryl Beryl [...]

Circular Economy Not Fulfilling Promise

The circular economy, a critical strategy for delivering a lower-emission, more sustainable future by reusing materials and minimising waste has made disappointingly little impact on the global plastics industry in the last decade as it struggled to navigate traditional value chains and business practices according to a new report by Wood Mackenzie. The July Horizons [...]

First Half of 2024: Boehringer Ingelheim Progresses Pipeline at Pace and Reaches Major Milestones

Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosis Strong first half net sales growth of 7.4%* year on year Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported on Thursday significant progress in its pipeline across key therapeutic areas as it [...]

Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma

SHANGHAI, July 17, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has accepted for review the supplemental new drug application (sNDA) for toripalimab (trade name: [...]

Io Therapeutics, Inc., Presented Today Results from Studies of IRX4204, the Company’s Phase II Clinical Development Stage, Highly Selective RXR Nuclear Receptor Agonist Compound, Supporting Its Potential Use for Treatment of Amyotrophic Lateral Sclerosis (ALS)

SPRING, Texas, July 16, 2024 (Korea Bizwire) – Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis (ALS). The presentation titled “The RXR Nuclear Receptor Agonist Compound IRX4204 is a [...]

Bedford Metals Identifies Key Uranium Markers at Close Lake Uranium Project

VANCOUVER, British Columbia, July 16, 2024 (Korea Bizwire) – Bedford Metals Corp. (TSX-V: BFM, FWB: O8D, ISIN: CA0762301012) (the “Company” or “Bedford”) is pleased to announce the results of its VNIR (Visible Near Field Infrared) and SWIR (Shortwave Infrared) satellite investigation at the Close Lake Uranium Project in the Athabasca Basin, Saskatchewan. An analysis conducted by Dr. [...]